Pre-Clinical Pharmacokinetics, Tissue Distribution and Physicochemical Studies of CLBQ14, a Novel Methionine Aminopeptidase Inhibitor for the Treatment of Infectious Diseases.

Oscar EkpenyongXiuqing GaoJing MaCandace CooperLinh NguyenOmonike A OlaleyeDong LiangHuan Xie

Published in: Drug design, development and therapy (2020)

CLBQ14 possess appealing qualities of a drug candidate. The studies reported herein are imperative to the development of CLBQ14 as a new chemical entity for infectious diseases.

Keyphrases

infectious diseases
case control
emergency department
amino acid
adverse drug
drug induced